{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:33:06Z","timestamp":1769049186938,"version":"3.49.0"},"reference-count":51,"publisher":"BMJ","issue":"8","funder":[{"name":"A + charitable trust"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,6,23]]},"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Post-transplant diabetes mellitus (PTDM) is a common complication of kidney transplantation and is associated with significant morbidity and mortality. In the general population, metformin has been used for diabetes prevention in high-risk individuals. Improving insulin sensitivity is one of many proven favourable effects of metformin. Despite the high incidence of PTDM in kidney transplant recipients, there is a lack of evidence for the role of metformin in the prevention of diabetes in this setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p><jats:italic>Trans<\/jats:italic>plantation and<jats:italic>Diab<\/jats:italic>etes (Transdiab<jats:bold>)<\/jats:bold>is a single-centre, unblinded, pilot randomised controlled trial assessing the feasibility, tolerability and efficacy of metformin after renal transplantation in patients with impaired glucose tolerance (IGT). Participants will undergo an oral glucose tolerance test in the 4\u201312 weeks post-transplantation; those with IGT will be randomised to standard care or standard care and metformin 500\u2009mg twice daily, and followed up for 12 months. The primary outcomes of the study will be the feasibility of recruitment, the tolerability of metformin assessed using the Gastrointestinal Symptom Rating Scale at 3 and 12 months, and the efficacy of metformin assessed by morning glucose and glycated haemoglobin at 3, 6, 9 and 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Despite the significant morbidity and mortality of PTDM, there are currently no randomised clinical trials assessing pharmacological interventions for its prevention after kidney transplantation. The Transdiab trial will thus provide important data on the feasibility, safety, tolerability and efficacy of metformin after renal transplantation in patients with IGT; this will facilitate undertaking larger multicentre trials of interventions to reduce the incidence or severity of diabetes after kidney transplantation. This study has been approved by the Northern B Health and Disability Ethics Committee of the Ministry of Health in New Zealand. On study completion, results are expected to be published in a peer-reviewed journal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>Australian New Zealand Clinical Trials Registry Number: ACTRN12614001171606.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2017-016813","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:10:18Z","timestamp":1503619818000},"page":"e016813","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Protocol for a pilot randomised controlled trial of metformin in pre-diabetes after kidney transplantation: the Transplantation and Diabetes (Transdiab) study"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-0030","authenticated-orcid":false,"given":"Basil","family":"Alnasrallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Pilmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Manley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,8,23]]},"reference":[{"key":"2024051614000217000_7.8.e016813.1","unstructured":"ANZDATA Registry. 37th Report, Preliminary Report 2014: Summary of Dialysis and Transplantation in Australia and New Zealand. Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia, 2015. http:\/\/www.anzdata.org.au."},{"key":"2024051614000217000_7.8.e016813.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510110079036"},{"key":"2024051614000217000_7.8.e016813.3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.12.2212"},{"key":"2024051614000217000_7.8.e016813.4","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.307"},{"key":"2024051614000217000_7.8.e016813.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2008.01073.x"},{"key":"2024051614000217000_7.8.e016813.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.09.011"},{"key":"2024051614000217000_7.8.e016813.7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000116"},{"key":"2024051614000217000_7.8.e016813.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2002.kid582.x"},{"key":"2024051614000217000_7.8.e016813.9","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e32832dbb98"},{"key":"2024051614000217000_7.8.e016813.10","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2001.150202.x"},{"key":"2024051614000217000_7.8.e016813.11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000116"},{"key":"2024051614000217000_7.8.e016813.12","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00010.x"},{"key":"2024051614000217000_7.8.e016813.13","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-S008"},{"key":"2024051614000217000_7.8.e016813.14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04681107"},{"key":"2024051614000217000_7.8.e016813.15","unstructured":"New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 2003."},{"key":"2024051614000217000_7.8.e016813.16","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12850"},{"key":"2024051614000217000_7.8.e016813.17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"2024051614000217000_7.8.e016813.18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080929"},{"key":"2024051614000217000_7.8.e016813.19","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00082.x"},{"key":"2024051614000217000_7.8.e016813.20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007111202"},{"key":"2024051614000217000_7.8.e016813.21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1051-2276(96)90103-X","article-title":"Changes in clinical profile and dietary considerations after renal transplantation","volume":"6","author":"Jaggers","year":"1996","journal-title":"J Renal Nutr"},{"key":"2024051614000217000_7.8.e016813.22","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199310000-00008"},{"key":"2024051614000217000_7.8.e016813.23","first-page":"21","article-title":"Hyperlipidemia and obesity after renal transplantation","volume":"6","author":"Teplan","year":"2001","journal-title":"Ann Transplant"},{"key":"2024051614000217000_7.8.e016813.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(01)00723-7"},{"key":"2024051614000217000_7.8.e016813.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2003.09.005"},{"key":"2024051614000217000_7.8.e016813.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-15-148"},{"key":"2024051614000217000_7.8.e016813.27","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-9920"},{"key":"2024051614000217000_7.8.e016813.28","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05360709"},{"key":"2024051614000217000_7.8.e016813.29","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg338"},{"key":"2024051614000217000_7.8.e016813.30","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-S008"},{"issue":"Suppl1","key":"2024051614000217000_7.8.e016813.31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1055\/s-0029-1240928","article-title":"A European evidence-based guideline for the prevention of type 2 diabetes","volume":"42 Suppl 1","author":"Paulweber","year":"2010","journal-title":"Horm Metab Res"},{"key":"2024051614000217000_7.8.e016813.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61457-4"},{"key":"2024051614000217000_7.8.e016813.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2534-0"},{"key":"2024051614000217000_7.8.e016813.34","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0416-8"},{"key":"2024051614000217000_7.8.e016813.35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-6-12","article-title":"Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study","volume":"6","author":"Kulich","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"2024051614000217000_7.8.e016813.36","doi-asserted-by":"publisher","DOI":"10.1007\/BF01535722"},{"key":"2024051614000217000_7.8.e016813.37","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2441"},{"key":"2024051614000217000_7.8.e016813.38","doi-asserted-by":"publisher","DOI":"10.1177\/14746514010010010501"},{"key":"2024051614000217000_7.8.e016813.39","unstructured":"Bailey CJ , Campbell IW , Chan JCN , et al , eds. Metformin, the gold standard: a scientific handbook. Chichester: Wiley, 2007:173\u201392."},{"key":"2024051614000217000_7.8.e016813.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"2024051614000217000_7.8.e016813.41","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.6.925"},{"key":"2024051614000217000_7.8.e016813.42","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.3.539"},{"key":"2024051614000217000_7.8.e016813.43","doi-asserted-by":"crossref","unstructured":"Salpeter SR , Greyber E , Pasternak GA , et al . Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010:CD002967.doi:10.1002\/14651858.CD002967.pub3","DOI":"10.1002\/14651858.CD002967.pub4"},{"key":"2024051614000217000_7.8.e016813.44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15298"},{"key":"2024051614000217000_7.8.e016813.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"2024051614000217000_7.8.e016813.46","first-page":"27","article-title":"Effectiveness of metformin on weight loss in non-diabetic individuals with obesity","volume":"121","author":"Seifarth","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2024051614000217000_7.8.e016813.47","unstructured":"University of Oxford Diabetes Trials Unit. Glucose lowering in non-diabetic hyperglycaemia trial (ongoing). https:\/\/www.dtu.ox.ac.uk\/GLINT\/ (accessed Jan 2015)."},{"key":"2024051614000217000_7.8.e016813.48","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2175"},{"key":"2024051614000217000_7.8.e016813.49","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1380"},{"key":"2024051614000217000_7.8.e016813.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00450.x"},{"key":"2024051614000217000_7.8.e016813.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.23.2823"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-016813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T21:00:23Z","timestamp":1715893223000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-016813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,23]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1136\/bmjopen-2017-016813"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-016813","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}